Written Language Intervention for Developmental Disabilities
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a written language intervention can help young adults with intellectual and developmental disabilities improve their reading and writing skills. The treatment involves weekly sessions using everyday texts, delivered through telepractice (online sessions). Researchers will monitor participants over three months to assess improvements in functional literacy. Individuals with intellectual or developmental disabilities who can read most words, have practical literacy needs, and use English as their primary spoken language might be a good fit.
As an unphased trial, this study offers participants the chance to enhance their literacy skills through innovative online methods.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this written language intervention is safe for young adults with intellectual and developmental disabilities?
Research shows that programs like the one being studied, which help people improve their reading and writing, are generally safe. These programs don't use medicine or involve any physical procedures, so there are usually no medical side effects to consider.
In past studies, similar programs were well-received. Participants often noticed improvements in their language skills without negative effects. Since this treatment is educational and doesn't involve physical intervention, it is considered safe for participants. Those considering joining this type of trial can feel confident about its safety.12345Why are researchers excited about this trial?
Researchers are excited about the written language intervention for developmental disabilities because it is delivered via telepractice, offering a more flexible and accessible option compared to traditional in-person therapies. Unlike standard treatments that often require physical attendance, this method allows participants to receive help from the comfort of their own homes, breaking down barriers related to location and mobility. Additionally, by focusing specifically on written language skills, this intervention targets an area that is frequently overshadowed by verbal communication therapies, potentially offering a more comprehensive approach to language development.
What evidence suggests that this written language intervention is effective for developmental disabilities?
Research has shown that writing programs can improve writing skills in people with intellectual and developmental disabilities. A review of studies found that these programs help children with these disabilities become better writers. Another analysis found that specific writing programs effectively aid students with learning disabilities. This trial will evaluate a written language intervention, providing participants with 3 months of weekly sessions via telepractice. Although limited data exists on young adults, practical writing exercises are believed to help them develop language skills, based on successes observed in other age groups.16789
Are You a Good Fit for This Trial?
This trial is for young adults with intellectual and developmental disabilities who can see normally or with correction, read most words on a screener, need to improve their functional literacy, primarily speak English and communicate orally.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 months of weekly written language intervention sessions via telepractice
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Written language intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator